TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.

Rulan Griesel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.